# FDA Inspection 1254544 - SigmaGraft Inc - April 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/sigmagraft-inc/703b6ad8-a7f3-4424-848f-9ea6b59b663a
Source feed: FDA_Inspections

> FDA Inspection 1254544 for SigmaGraft Inc on April 25, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254544
- Company Name: SigmaGraft Inc
- Inspection Date: 2025-04-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Los Angeles District Office

## Related Documents

- [FDA Inspection 1086611 - 2019-03-07](https://www.keypedia.com/records/fda_inspections/sigmagraft-inc/2900ecf9-bfb9-499f-860a-ed04bd8adb30)
- [FDA Inspection 1086611 - 2019-03-07](https://www.keypedia.com/records/fda_inspections/sigmagraft-inc/ecd93f2c-1348-4d13-af95-03a2e8465a81)
- [FDA Inspection 866325 - 2014-02-11](https://www.keypedia.com/records/fda_inspections/sigmagraft-inc/37b1df0a-aaa5-41bf-84ea-4e0ac5194433)
- [FDA Inspection 722533 - 2011-05-02](https://www.keypedia.com/records/fda_inspections/sigmagraft-inc/8dca0142-fc0b-4894-8bad-3702d912be1b)

Company: https://www.keypedia.com/companies/sigmagraft-inc/4a1f2860-52f0-475a-ad24-b89f3b73a921

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b